Omar, M.; Omar, M.; Patt, Y.S.; Ukashi, O.; Sharif, Y.; Lahat, A.; Selinger, C.P.; Sharif, K.
Genetic Risk of Ankylosing Spondylitis and Second-Line Therapy Need in Crohn’s Disease: A Mendelian Randomization Study. J. Clin. Med. 2024, 13, 7496.
https://doi.org/10.3390/jcm13247496
AMA Style
Omar M, Omar M, Patt YS, Ukashi O, Sharif Y, Lahat A, Selinger CP, Sharif K.
Genetic Risk of Ankylosing Spondylitis and Second-Line Therapy Need in Crohn’s Disease: A Mendelian Randomization Study. Journal of Clinical Medicine. 2024; 13(24):7496.
https://doi.org/10.3390/jcm13247496
Chicago/Turabian Style
Omar, Mahmud, Mohammad Omar, Yonatan Shneor Patt, Offir Ukashi, Yousra Sharif, Adi Lahat, Christian Phillip Selinger, and Kassem Sharif.
2024. "Genetic Risk of Ankylosing Spondylitis and Second-Line Therapy Need in Crohn’s Disease: A Mendelian Randomization Study" Journal of Clinical Medicine 13, no. 24: 7496.
https://doi.org/10.3390/jcm13247496
APA Style
Omar, M., Omar, M., Patt, Y. S., Ukashi, O., Sharif, Y., Lahat, A., Selinger, C. P., & Sharif, K.
(2024). Genetic Risk of Ankylosing Spondylitis and Second-Line Therapy Need in Crohn’s Disease: A Mendelian Randomization Study. Journal of Clinical Medicine, 13(24), 7496.
https://doi.org/10.3390/jcm13247496
